![]()
GONUTS is under stress! The website is currently experiencing long-wait times and frequent time-outs due to the record number of students, groups, and annotations related to CACAO this semester. We are currently working on increasing performance -- please accept our apologies for the technical difficulties.
You can help reduce stress on the server by:
- not reloading pages frequently - this just adds
- opening links in new windows (so you can read the old page)
HUMAN:GATA3
Contents |
| Species (Taxon ID) | Homo sapiens (Human). (taxon:9606) | |
| Gene Name(s) | GATA3 | |
| Protein Name(s) |
| |
| External Links | ||
| UniProt Identifier | GATA3_HUMAN | |
| UniProt Accessions | P23771, Q5VWG7, Q5VWG8, Q96J16, | |
| EMBL | X58072, X55037, X55122, M69106, AY497006, AL390294, AL390294, CH471072, CH471072, BC003070, BC006793, | |
| PIR | A39794, | |
| RefSeq | NP_001002295.1, NP_002042.1, | |
| Ensembl | ENST00000346208, | |
| Pfam | PF00320, | |
Annotations
| Qualifier | GO ID | GO term name | Reference | Evidence Code | with/from | Aspect | Notes | Status |
|---|---|---|---|---|---|---|---|---|
| GO:0005634 |
nucleus |
IDA: Inferred from Direct Assay |
C |
Source: LIFEdb |
||||
| GO:0071837 |
HMG box domain binding |
IPI: Inferred from Physical Interaction |
F |
Source: UniProtKB |
||||
| GO:0043565 |
sequence-specific DNA binding |
IEA: Inferred from Electronic Annotation |
F |
Source: InterPro |
||||
| GO:0003700 |
sequence-specific DNA binding transcription factor activity |
TAS: Traceable Author Statement |
F |
Source: ProtInc |
||||
| GO:0008134 |
transcription factor binding |
IPI: Inferred from Physical Interaction |
F |
Source: BHF-UCL |
||||
| GO:0008270 |
zinc ion binding |
IEA: Inferred from Electronic Annotation |
F |
Source: InterPro |
||||
| GO:0009653 |
anatomical structure morphogenesis |
TAS: Traceable Author Statement |
P |
Source: ProtInc |
||||
| GO:0006952 |
defense response |
TAS: Traceable Author Statement |
P |
Source: ProtInc |
||||
| GO:0006355 |
regulation of transcription, DNA-dependent |
IEA: Inferred from Electronic Annotation |
P |
Source: InterPro |
||||
| GO:0043627 |
response to estrogen stimulus |
IEP: Inferred from Expression Pattern |
P |
Source: UniProtKB |
||||
| GO:0070888 |
E-box binding |
IDA: Inferred from Direct Assay |
F |
using oligonucleotides that cover all E-boxes and GATA binding sites present in the −875/−570 human NKX3.1 promoter region, we found that TAL1 and GATA-3 can bind an E-box located at −738 and/or two GATA binding sites at −748 and −697 (Fig. 3 c) |
complete | |||
| GO:0006366 |
transcription from RNA polymerase II promoter |
TAS: Traceable Author Statement |
P |
Source: ProtInc |
||||
| GO:0000122 |
negative regulation of transcription from RNA polymerase II promoter |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0000790 |
nuclear chromatin |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0000976 |
transcription regulatory region sequence-specific DNA binding |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0000987 |
core promoter proximal region sequence-specific DNA binding |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0001046 |
core promoter sequence-specific DNA binding |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0001071 |
nucleic acid binding transcription factor activity |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0001071 |
nucleic acid binding transcription factor activity |
IMP: Inferred from Mutant Phenotype |
F |
|||||
| GO:0001071 |
nucleic acid binding transcription factor activity |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0001071 |
nucleic acid binding transcription factor activity |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0001071 |
nucleic acid binding transcription factor activity |
IMP: Inferred from Mutant Phenotype |
F |
|||||
| GO:0001078 |
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription |
IMP: Inferred from Mutant Phenotype |
F |
|||||
| GO:0001709 |
cell fate determination |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0001822 |
kidney development |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0001822 |
kidney development |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0001823 |
mesonephros development |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0003180 |
aortic valve morphogenesis |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0003215 |
cardiac right ventricle morphogenesis |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0003281 |
ventricular septum development |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0003677 |
DNA binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0003677 |
DNA binding |
TAS: Traceable Author Statement |
F |
|||||
| GO:0003700 |
sequence-specific DNA binding transcription factor activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0003700 |
sequence-specific DNA binding transcription factor activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0003700 |
sequence-specific DNA binding transcription factor activity |
TAS: Traceable Author Statement |
F |
|||||
| GO:0003700 |
sequence-specific DNA binding transcription factor activity |
TAS: Traceable Author Statement |
F |
|||||
| GO:0003713 |
transcription coactivator activity |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005634 |
nucleus |
IEA: Inferred from Electronic Annotation |
C |
|||||
| GO:0005634 |
nucleus |
IEA: Inferred from Electronic Annotation |
SP_SL:SL-0191 |
C |
||||
| GO:0005634 |
nucleus |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0005634 |
nucleus |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0005634 |
nucleus |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0005634 |
nucleus |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0005634 |
nucleus |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0005654 |
nucleoplasm |
Reactome:REACT_25215 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005730 |
nucleolus |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0006351 |
transcription, DNA-dependent |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0006355 |
regulation of transcription, DNA-dependent |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0006355 |
regulation of transcription, DNA-dependent |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0006355 |
regulation of transcription, DNA-dependent |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0006355 |
regulation of transcription, DNA-dependent |
TAS: Traceable Author Statement |
P |
|||||
| GO:0006355 |
regulation of transcription, DNA-dependent |
TAS: Traceable Author Statement |
P |
|||||
| GO:0006366 |
transcription from RNA polymerase II promoter |
TAS: Traceable Author Statement |
P |
|||||
| GO:0006952 |
defense response |
TAS: Traceable Author Statement |
P |
|||||
| GO:0007165 |
signal transduction |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0007596 |
blood coagulation |
Reactome:REACT_604 |
TAS: Traceable Author Statement |
P |
||||
| GO:0008134 |
transcription factor binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0008270 |
zinc ion binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0008270 |
zinc ion binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0008285 |
negative regulation of cell proliferation |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0008584 |
male gonad development |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0009615 |
response to virus |
IEP: Inferred from Expression Pattern |
P |
|||||
| GO:0009653 |
anatomical structure morphogenesis |
TAS: Traceable Author Statement |
P |
|||||
| GO:0009967 |
positive regulation of signal transduction |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0010595 |
positive regulation of endothelial cell migration |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0014065 |
phosphatidylinositol 3-kinase cascade |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0031929 |
TOR signaling cascade |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0032753 |
positive regulation of interleukin-4 production |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0035457 |
cellular response to interferon-alpha |
IEP: Inferred from Expression Pattern |
P |
|||||
| GO:0042035 |
regulation of cytokine biosynthetic process |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0042421 |
norepinephrine biosynthetic process |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0043565 |
sequence-specific DNA binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0043583 |
ear development |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0043583 |
ear development |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0043627 |
response to estrogen stimulus |
IEP: Inferred from Expression Pattern |
P |
|||||
| GO:0044212 |
transcription regulatory region DNA binding |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0044212 |
transcription regulatory region DNA binding |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0044212 |
transcription regulatory region DNA binding |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0044212 |
transcription regulatory region DNA binding |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0045582 |
positive regulation of T cell differentiation |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0045599 |
negative regulation of fat cell differentiation |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0045786 |
negative regulation of cell cycle |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0045892 |
negative regulation of transcription, DNA-dependent |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0045893 |
positive regulation of transcription, DNA-dependent |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0045893 |
positive regulation of transcription, DNA-dependent |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0045893 |
positive regulation of transcription, DNA-dependent |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0045893 |
positive regulation of transcription, DNA-dependent |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0045893 |
positive regulation of transcription, DNA-dependent |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0046872 |
metal ion binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0048485 |
sympathetic nervous system development |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0048646 |
anatomical structure formation involved in morphogenesis |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0050728 |
negative regulation of inflammatory response |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0050852 |
T cell receptor signaling pathway |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0051897 |
positive regulation of protein kinase B signaling cascade |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0060037 |
pharyngeal system development |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0060065 |
uterus development |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0060231 |
mesenchymal to epithelial transition |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0060676 |
ureteric bud formation |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0061290 |
canonical Wnt receptor signaling pathway involved in metanephric kidney development |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0070888 |
E-box binding |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0071353 |
cellular response to interleukin-4 |
IEP: Inferred from Expression Pattern |
P |
|||||
| GO:0071356 |
cellular response to tumor necrosis factor |
IEP: Inferred from Expression Pattern |
P |
|||||
| GO:0071837 |
HMG box domain binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0072107 |
positive regulation of ureteric bud formation |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0072178 |
nephric duct morphogenesis |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0072179 |
nephric duct formation |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0072182 |
regulation of nephron tubule epithelial cell differentiation |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0072676 |
lymphocyte migration |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:2000146 |
negative regulation of cell motility |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:2000352 |
negative regulation of endothelial cell apoptosis |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:2000607 |
negative regulation of cell proliferation involved in mesonephros development |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:2000611 |
positive regulation of thyroid hormone generation |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:2000611 |
positive regulation of thyroid hormone generation |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:2000664 |
positive regulation of interleukin-5 secretion |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:2000667 |
positive regulation of interleukin-13 secretion |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:2000667 |
positive regulation of interleukin-13 secretion |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:2000679 |
positive regulation of transcription regulatory region DNA binding |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:2000683 |
regulation of cellular response to X-ray |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:2000703 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:2000734 |
negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
|
NOT |
GO:0005730 |
nucleolus |
IDA: Inferred from Direct Assay |
C |
| |||
| edit table |
Notes
References
See Help:References for how to manage references in GONUTS.
- ↑ 1.0 1.1 1.2 1.3 Kusy S et al. (2010) NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia. J Exp Med 207: 2141-56 PubMed GONUTS page
- ↑ 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 2.12 2.13 2.14 Song H et al. (2009) Critical role for GATA3 in mediating Tie2 expression and function in large vessel endothelial cells. J Biol Chem 284: 29109-24 PubMed GONUTS page
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 Gaynor KU et al. (2009) A missense GATA3 mutation, Thr272Ile, causes the hypoparathyroidism, deafness, and renal dysplasia syndrome. J Clin Endocrinol Metab 94: 3897-904 PubMed GONUTS page
- ↑ 4.0 4.1 4.2 Son do N et al. (2009) Abundant expression of Kallikrein 1 gene in human keratinocytes was mediated by GATA3. Gene 436: 121-7 PubMed GONUTS page
- ↑ 5.0 5.1 5.2 5.3 Jenner RG et al. (2009) The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes. Proc Natl Acad Sci U S A 106: 17876-81 PubMed GONUTS page
- ↑ 6.0 6.1 6.2 6.3 6.4 6.5 6.6 Yan W et al. (2010) GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. J Biol Chem 285: 14042-51 PubMed GONUTS page
- ↑ 7.0 7.1 7.2 7.3 Yao X et al. (2010) GATA3 siRNA inhibits the binding of NFAT1 to interleukin-13 promoter in human T cells. Chin Med J (Engl) 123: 739-44 PubMed GONUTS page
- ↑ 8.0 8.1 8.2 Ferraris S et al. (2009) HDR syndrome: a novel "de novo" mutation in GATA3 gene. Am J Med Genet A 149A: 770-5 PubMed GONUTS page
- ↑ 9.0 9.1 Marine J & Winoto A (1991) The human enhancer-binding protein Gata3 binds to several T-cell receptor regulatory elements. Proc Natl Acad Sci U S A 88: 7284-8 PubMed GONUTS page
- ↑ 10.0 10.1 Joulin V et al. (1991) A T-cell specific TCR delta DNA binding protein is a member of the human GATA family. EMBO J 10: 1809-16 PubMed GONUTS page
- ↑ 11.0 11.1 Labastie MC et al. (1994) Structure and expression of the human GATA3 gene. Genomics 21: 1-6 PubMed GONUTS page
- ↑ 12.0 12.1 12.2 12.3 12.4 Nakata Y et al. (2010) c-Myb, Menin, GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell development. Blood 116: 1280-90 PubMed GONUTS page
- ↑ Simpson JC et al. (2000) Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. EMBO Rep 1: 287-92 PubMed GONUTS page
- ↑ 14.0 14.1 14.2 Barbe L et al. (2008) Toward a confocal subcellular atlas of the human proteome. Mol Cell Proteomics 7: 499-508 PubMed GONUTS page
- ↑ Siegel MD et al. (1995) Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements. J Biol Chem 270: 24548-55 PubMed GONUTS page
- ↑ Minami T et al. (2004) Interaction between hex and GATA transcription factors in vascular endothelial cells inhibits flk-1/KDR-mediated vascular endothelial growth factor signaling. J Biol Chem 279: 20626-35 PubMed GONUTS page
- ↑ Díaz YR et al. (2010) T-bet, GATA-3, and Foxp3 expression and Th1/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species. J Infect Dis 202: 406-15 PubMed GONUTS page
- ↑ Van Esch H et al. (2000) GATA3 haplo-insufficiency causes human HDR syndrome. Nature 406: 419-22 PubMed GONUTS page
- ↑ Dydensborg AB et al. (2009) GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis. Oncogene 28: 2634-42 PubMed GONUTS page
- ↑ 20.0 20.1 20.2 20.3 Huber JP et al. (2010) Cutting edge: Type I IFN reverses human Th2 commitment and stability by suppressing GATA3. J Immunol 185: 813-7 PubMed GONUTS page
- ↑ Yang GP et al. (1999) Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. Nucleic Acids Res 27: 1517-23 PubMed GONUTS page
- ↑ 22.0 22.1 Bonin F et al. (2009) GATA3 is a master regulator of the transcriptional response to low-dose ionizing radiation in human keratinocytes. BMC Genomics 10: 417 PubMed GONUTS page
- ↑ Jack BH & Crossley M (2010) GATA proteins work together with friend of GATA (FOG) and C-terminal binding protein (CTBP) co-regulators to control adipogenesis. J Biol Chem 285: 32405-14 PubMed GONUTS page
- ↑ Hossain MB et al. (2008) Lymphoid enhancer factor interacts with GATA-3 and controls its function in T helper type 2 cells. Immunology 125: 377-86 PubMed GONUTS page